Mastek Limited (NSE: MASTEK)
India
· Delayed Price · Currency is INR | Market Cap | 91.49B |
| Revenue (ttm) | 32.54B |
| Net Income (ttm) | 3.68B |
| Shares Out | 30.88M |
| EPS (ttm) | 118.52 |
| PE Ratio | 25.00 |
| Forward PE | 22.93 |
| Dividend | 19.00 (0.64%) |
| Ex-Dividend Date | Sep 17, 2024 |
| Volume | 34,208 |
| Open | 3,026.95 |
| Previous Close | 3,019.40 |
| Day's Range | 2,972.70 - 3,039.25 |
| 52-Week Range | 2,137.55 - 3,375.00 |
| Beta | 1.28 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jan 31, 2025 |
About Mastek
Mastek Limited, together with its subsidiaries, engages in the provision of enterprise technology solutions in India, the United Kingdom, Europe, North America, Middle East region, South-east Asia, India, Singapore, Australia, and internationally. The company offers digital and application engineering, including platform engineering, cloud engineering and migration, enterprise integration, microservices, low code, quality engineering, IPaaS, DevSecOps, and API solutions. It also provides oracle cloud and enterprise apps, such as E-business suit... [Read more]
Financial Performance
In 2023, Mastek's revenue was 30.55 billion, an increase of 19.17% compared to the previous year's 25.63 billion. Earnings were 3.00 billion, an increase of 2.48%.
Financial StatementsNews
Mastek CFO Arun Agarwal resigns
Mastek Limited has announced the resignation of its Global Chief Financial Officer (CFO) and Key Managerial Personnel, Arun Agarwal, effective December 3, 2024. The resignation was communicated throug...
Macquarie maintains outperform on Mastek, sees 17.7% upside with target hiked to Rs 3,320
Macquarie has reiterated its outperform rating on Mastek, raising the target price to ₹3,320 from ₹3,120, which implies an upside potential of 17.7% from the CMP of ₹2,820. The brokerage cited success...
Mastek and Innovaccer join forces to enhance healthcare service offerings
Mastek, a digital engineering firm, has recently announced a partnership with Innovaccer, a healthcare AI company, to enhance healthcare service offerings. The partnership leverages Innovaccer’s AI an...
Mastek Q2 Results: Revenue rises 13.33% YoY to Rs 86.74 crore, net profit jumps 104.74% YoY to Rs 128.65 crore
Mastek Limited has reported strong financial results for the second quarter ending September 30, 2024. The company’s revenue from operations increased by 13.33% year-on-year (YoY) to ₹86.74 crore, com...
Q2 results today: Mastek up 1.55%, Hindustan Zinc falls 0.91%, Tata Consumer down 0.82%, ICICI Lombard down 0.60% ahead of Q2 results release
Several major companies, including Hindustan Zinc, Tata Consumer Products, and ICICI Lombard, are set to announce their Q2 FY25 results today. Investors are watching closely to see how these firms hav...
Q2FY25 Results on 18th October 2024: Hindustan Zinc, L&T Finance, Tata Consumer Products, Zee Entertainment and more
Several major companies are expected to report their Q2FY25 earnings on 18th October 2024, including Hindustan Zinc, ICICI General Insurance, L&T Finance, Mastek, Oberoi Realty, Tata Consumer Products...
Mastek partners with Onyx Health to boost healthcare data interoperability, shares surge over 2%
Mastek shares surged over 2% on Wednesday after announcing its partnership with Onyx Health. As of 11:25 am the shares of Mastek were trading 1.88% higher at ₹3,057.00 on NSE, Mastek, a leading digita...